|
FR2663336B1
(fr)
|
1990-06-18 |
1992-09-04 |
Adir |
Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
|
FR2713225B1
(fr)
|
1993-12-02 |
1996-03-01 |
Sanofi Sa |
N-pipéridino-3-pyrazolecarboxamide substitué.
|
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
|
CZ220498A3
(cs)
|
1996-01-17 |
1998-11-11 |
Novo Nordisk A/S |
Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
|
|
WO1997041097A2
(fr)
|
1996-12-31 |
1997-11-06 |
Dr. Reddy's Research Foundation |
Nouveaux composes heterocycliques, leur procede de preparation, compositions pharmaceutiques les contenant et utilisation de ces composes dans le traitement du diabete et des maladies associees
|
|
DE122009000079I2
(de)
|
1996-08-30 |
2011-06-16 |
Novo Nordisk As Novo Alle |
Glp-1 derivate
|
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
|
AU757693B2
(en)
|
1997-07-16 |
2003-03-06 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
|
CO4970713A1
(es)
|
1997-09-19 |
2000-11-07 |
Sanofi Synthelabo |
Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen
|
|
EP1063235B1
(fr)
|
1998-03-12 |
2004-05-12 |
Teijin Limited |
Derives de benzofurylpyrone
|
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
FR2783246B1
(fr)
|
1998-09-11 |
2000-11-17 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les medicaments les contenant
|
|
DE19845405C2
(de)
|
1998-10-02 |
2000-07-13 |
Aventis Pharma Gmbh |
Arylsubstituierte Propanolaminderivate und deren Verwendung
|
|
EP1137667B1
(fr)
|
1998-12-07 |
2004-11-17 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Analogues du glp-1
|
|
GB9900416D0
(en)
|
1999-01-08 |
1999-02-24 |
Alizyme Therapeutics Ltd |
Inhibitors
|
|
US6608185B1
(en)
|
1999-03-25 |
2003-08-19 |
Kitasato Institute |
Substances KF-1040T4A,KF-1040T4B, KF-1040T5A, and KF-1040T5B, and process for producing same
|
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
EP1173438A1
(fr)
|
1999-04-16 |
2002-01-23 |
Novo Nordisk A/S |
Imidazoles substitues, leur preparation et utilisation
|
|
WO2000064884A1
(fr)
|
1999-04-26 |
2000-11-02 |
Novo Nordisk A/S |
Derives de piperidyle-imidazole, preparations dans lesquelles ils entrent et utilisations therapeutiques de ces dernieres
|
|
JP2002543200A
(ja)
|
1999-04-30 |
2002-12-17 |
ニューロゲン コーポレイション |
9H−ピリミド[4、5−b]インドール誘導体:CRF1特異性リガンド
|
|
GB9911863D0
(en)
|
1999-05-21 |
1999-07-21 |
Knoll Ag |
Therapeutic agents
|
|
WO2000077001A1
(fr)
|
1999-06-15 |
2000-12-21 |
Du Pont Pharmaceuticals Company |
Gamma-carbolines fusionnees a heterocycles substitues
|
|
HK1047582B
(zh)
|
1999-06-23 |
2005-03-04 |
萨诺费-阿文蒂斯德国有限公司 |
取代的苯並咪唑
|
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
|
EP1076066A1
(fr)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides abaissant le taux de glucose sanguin
|
|
CA2378878A1
(fr)
|
1999-07-29 |
2001-02-08 |
Jeffrey Thomas Mullaney |
Benzofurylpiperazines et benzofurylhomopiperazines: antagonistes de la serotonine
|
|
FR2796945B1
(fr)
*
|
1999-07-30 |
2002-06-28 |
Sod Conseils Rech Applic |
Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments
|
|
CA2383781A1
(fr)
|
1999-09-01 |
2001-03-08 |
Aventis Pharma Deutschland Gmbh |
Derives de sulfonylcarboxamide, leur procede de production et leur utilisation comme medicaments
|
|
EP1214324B1
(fr)
|
1999-09-10 |
2006-06-14 |
Novo Nordisk A/S |
MODULATEURS DE PROTEINE TYROSINE PHOSPHATASE (PTPases)
|
|
WO2001017516A2
(fr)
|
1999-09-10 |
2001-03-15 |
Novo Nordisk A/S |
Procede d'inhibition de la proteine tyrosine phosphatase 1b et/ou de la proteine tyrosine phosphatase de lymphocytes et/ou d'autres ptpases possedant un reste aps en position 48
|
|
DE19951360A1
(de)
|
1999-10-26 |
2001-05-03 |
Aventis Pharma Gmbh |
Substituierte Indole
|
|
FR2800375B1
(fr)
|
1999-11-03 |
2004-07-23 |
Sanofi Synthelabo |
Derives tricycliques d'acide pyrazolecarboxylique, leur preparation, les compositions pharmaceutiques en contenant
|
|
PE20011010A1
(es)
|
1999-12-02 |
2001-10-18 |
Glaxo Group Ltd |
Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
|
|
FR2805817B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
|
|
FR2805818B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
|
|
FR2805810B1
(fr)
|
2000-03-03 |
2002-04-26 |
Aventis Pharma Sa |
Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
|
|
PL208098B1
(pl)
|
2000-03-23 |
2011-03-31 |
Solvay Pharm Bv |
Pochodne 4,5-dihydro-1H-pirazolu, kompozycja farmaceutyczna, sposób wytwarzania związków oraz ich zastosowanie
|
|
KR20020089420A
(ko)
|
2000-03-31 |
2002-11-29 |
화이자 프로덕츠 인코포레이티드 |
갑상선 수용체 리간드로서의 말로남산 및 그의 유도체
|
|
WO2001083451A1
(fr)
|
2000-04-28 |
2001-11-08 |
Asahi Kasei Kabushiki Kaisha |
Nouveaux composés bicycliques
|
|
JP2004507456A
(ja)
|
2000-05-11 |
2004-03-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
成長ホルモン分泌促進薬として有用なテトラヒドロイソキノリン類縁体
|
|
WO2001085693A1
(fr)
|
2000-05-11 |
2001-11-15 |
Banyu Pharmaceutical Co., Ltd. |
Dérivés n-acyltétrahydroisoquinoline
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
EP1289526A4
(fr)
|
2000-05-30 |
2005-03-16 |
Merck & Co Inc |
Agonistes du recepteur de la melanocortine
|
|
US6395784B1
(en)
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
|
EP1289955B1
(fr)
|
2000-06-16 |
2005-04-13 |
Smithkline Beecham Plc |
Piperidines utiles en tant qu'antagonistes du recepteur d'orexine
|
|
EP1299362A4
(fr)
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
Antagonistes selectifs des recepteurs (mch1) d'hormone-1 de concentration de la melanine et utilisation de ceux-ci
|
|
WO2002002744A2
(fr)
|
2000-07-05 |
2002-01-10 |
Synaptic Pharmaceutical Corporation |
Adn codant pour un recepteur humain de l'hormone de concentration de la melanine (mch1) et ses applications
|
|
DE60106641T2
(de)
|
2000-11-03 |
2005-12-01 |
Wyeth |
Cyclopenta[b][1,4] diazepino[6,7,1-hi]indole als 5ht2c antagonisten
|
|
DE60120748T2
(de)
|
2000-11-10 |
2007-05-16 |
Eli Lilly And Co., Indianapolis |
3-substituierte oxindolderivate als beta-3-agonisten
|
|
HUP0004741A2
(hu)
|
2000-11-28 |
2002-12-28 |
Sanofi-Synthelabo |
Kémiai eljárás tiazolszármazékok előállítására és új intermedier
|
|
CA2431995A1
(fr)
|
2000-12-21 |
2002-06-27 |
Aventis Pharma Deutschland Gmbh |
Derives de diphenylazetinone, procede permettant de les produire, medicaments contenant lesdits composes et leur utilisation
|
|
BR0116493A
(pt)
|
2000-12-21 |
2003-09-30 |
Vertex Pharma |
Compostos de pirazol úteis como inibidores de proteìna cinase
|
|
IL156550A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
|
IL156552A0
(en)
|
2000-12-21 |
2004-01-04 |
Aventis Pharma Gmbh |
Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
|
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
|
CZ2003698A3
(cs)
|
2001-03-22 |
2003-06-18 |
Solvay Pharmaceuticals B. V. |
4,5-Dihydro-1H-pyrazolové deriváty mající CB1-antagonistickou účinnost
|
|
ES2319619T3
(es)
|
2001-05-04 |
2009-05-11 |
Amgen Inc. |
Compuestos heterociclicos condensados.
|
|
GB0113233D0
(en)
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
CN100507079C
(zh)
|
2001-06-28 |
2009-07-01 |
阿洛尼姆农业合作社控股有限公司 |
阳极化镁和镁合金的方法及在阳极化的表面上产生导电层的方法
|
|
MXPA03011886A
(es)
|
2001-07-05 |
2005-03-07 |
Lundbeck & Co As H |
Piperidinias anilinicas sustituidas como antagonistas selectivos de mch.
|
|
AU2002319627A1
(en)
|
2001-07-20 |
2003-03-03 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
|
WO2003013571A1
(fr)
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetiques de metallopeptides biologiquement actifs
|
|
US7732451B2
(en)
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
|
US7655658B2
(en)
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
|
DE10139416A1
(de)
|
2001-08-17 |
2003-03-06 |
Aventis Pharma Gmbh |
Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE10142734A1
(de)
|
2001-08-31 |
2003-03-27 |
Aventis Pharma Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2007036945A2
(fr)
|
2005-09-30 |
2007-04-05 |
Compugen Ltd. |
Variants d'epissure du recepteur du facteur de croissance des hepatocytes et methodes d'utilisation
|
|
CN101659639A
(zh)
|
2001-09-21 |
2010-03-03 |
索尔瓦药物有限公司 |
具有cb1-拮抗活性的新的4,5-二氢-1h-吡唑衍生物
|
|
US7109216B2
(en)
|
2001-09-21 |
2006-09-19 |
Solvay Pharmaceuticals B.V. |
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
|
|
US6509367B1
(en)
|
2001-09-22 |
2003-01-21 |
Virginia Commonwealth University |
Pyrazole cannabinoid agonist and antagonists
|
|
PE20030547A1
(es)
|
2001-09-24 |
2003-08-18 |
Bayer Corp |
Derivados de imidazol para el tratamiento de la obesidad
|
|
JP2005532982A
(ja)
|
2001-09-24 |
2005-11-04 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
肥満の処置のためのピロール誘導体の製造及び使用
|
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
|
IL161154A0
(en)
|
2001-11-22 |
2004-08-31 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
AU2002353716A1
(en)
|
2001-11-22 |
2003-06-10 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
EP1461327A1
(fr)
|
2001-11-22 |
2004-09-29 |
Biovitrum Ab |
Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase de type 1
|
|
GB0202015D0
(en)
|
2002-01-29 |
2002-03-13 |
Hoffmann La Roche |
Piperazine Derivatives
|
|
WO2003065983A2
(fr)
|
2002-02-01 |
2003-08-14 |
Merck & Co., Inc. |
Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase 1 utiles pour le traitement du diabete, de l'obesite et de la dyslipidemie
|
|
US20050124652A1
(en)
|
2002-02-04 |
2005-06-09 |
Rustum Boyce |
Guanidino compounds
|
|
WO2003072197A1
(fr)
|
2002-02-27 |
2003-09-04 |
Pfizer Products Inc. |
Inhibiteurs de l'acetyl-coa-carboxylase
|
|
ES2276048T3
(es)
|
2002-03-05 |
2007-06-16 |
Eli Lilly And Company |
Derivados de purina como inhibidores de cinasa.
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
AU2003226149A1
(en)
|
2002-04-05 |
2003-10-27 |
Merck & Co., Inc. |
Substituted aryl amides
|
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
|
FR2838438A1
(fr)
|
2002-04-11 |
2003-10-17 |
Sanofi Synthelabo |
Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant
|
|
DE10215907A1
(de)
|
2002-04-11 |
2003-11-06 |
Aventis Pharma Gmbh |
Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
FR2838439B1
(fr)
|
2002-04-11 |
2005-05-20 |
Sanofi Synthelabo |
Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
|
|
EP1499306A4
(fr)
|
2002-04-12 |
2007-03-28 |
Merck & Co Inc |
Amides bicycliques
|
|
WO2003097064A1
(fr)
|
2002-05-17 |
2003-11-27 |
Kyowa Hakko Kogyo Co., Ltd. |
Agent de traitement du diabète
|
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
|
DE10226462A1
(de)
|
2002-06-13 |
2003-12-24 |
Aventis Pharma Gmbh |
Fluorierte Cycloalkyl-derivatisierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
|
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
|
DE10227508A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE10227507A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE10227506A1
(de)
|
2002-06-19 |
2004-01-08 |
Aventis Pharma Deutschland Gmbh |
Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
US20040002524A1
(en)
|
2002-06-24 |
2004-01-01 |
Richard Chesworth |
Benzimidazole compounds and their use as estrogen agonists/antagonists
|
|
US7649012B2
(en)
|
2002-07-09 |
2010-01-19 |
Fasgen, Inc. |
Compounds, pharmaceutical compositions containing same, and methods of use for same
|
|
AU2003248888A1
(en)
|
2002-07-09 |
2004-01-23 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
AU2003249937A1
(en)
|
2002-07-12 |
2004-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclically substituted benzoylureas, method for their production and their use as medicaments
|
|
IL150914A
(en)
|
2002-07-25 |
2014-04-30 |
Zamir Tribelsky |
Method for hydro-optronic photochemical treatment of liquids
|
|
DE10233817A1
(de)
|
2002-07-25 |
2004-02-12 |
Aventis Pharma Deutschland Gmbh |
Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US20050272036A1
(en)
|
2002-07-27 |
2005-12-08 |
Barton Peter J |
Ketones
|
|
AU2003250117B2
(en)
|
2002-07-29 |
2007-05-10 |
F. Hoffmann-La Roche Ag |
Novel benzodioxoles
|
|
EP1537106A1
(fr)
|
2002-08-07 |
2005-06-08 |
Mitsubishi Pharma Corporation |
Composes de dihydropyrazolopyridine
|
|
GB0219022D0
(en)
|
2002-08-15 |
2002-09-25 |
Karobio Ab |
Novel thyromimetic compounds
|
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
|
PL374946A1
(en)
|
2002-09-05 |
2005-11-14 |
Aventis Pharma S.A. |
Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
|
|
US7414057B2
(en)
|
2002-09-11 |
2008-08-19 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
|
AU2003275242B2
(en)
|
2002-09-27 |
2010-03-04 |
Merck Sharp & Dohme Corp. |
Substituted pyrimidines
|
|
KR20050051691A
(ko)
|
2002-10-11 |
2005-06-01 |
아스트라제네카 아베 |
1,4-이치환 피페리딘 유도체 및 11-베타hsd1억제제로서의 이들의 용도
|
|
BR0314872A
(pt)
|
2002-10-18 |
2005-08-02 |
Pfizer Prod Inc |
Ligandos do receptor canabinóide e usos dos mesmos
|
|
HRP20050343A2
(en)
|
2002-10-18 |
2007-03-31 |
Merck & Co. Inc. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
US7132539B2
(en)
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
KR20050059294A
(ko)
|
2002-10-24 |
2005-06-17 |
스테릭스 리미티드 |
11-베타-하이드록시 스테로이드 데하이드로게나제 형태 1및 형태 2의 억제제
|
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US20060122240A1
(en)
|
2002-11-05 |
2006-06-08 |
Arena Pharmaceuticals, Inc. |
Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof
|
|
JP2006514102A
(ja)
|
2002-11-07 |
2006-04-27 |
アストラゼネカ アクチボラグ |
2−オキソ−エタンスルホンアミド誘導体
|
|
FR2847253B1
(fr)
|
2002-11-19 |
2007-05-18 |
Aventis Pharma Sa |
Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
MY134457A
(en)
|
2002-11-22 |
2007-12-31 |
Merck & Co Inc |
Substituted amides
|
|
GB0227813D0
(en)
|
2002-11-29 |
2003-01-08 |
Astrazeneca Ab |
Chemical compounds
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
DE10258008B4
(de)
|
2002-12-12 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
DE10258007B4
(de)
|
2002-12-12 |
2006-02-09 |
Sanofi-Aventis Deutschland Gmbh |
Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
WO2004058145A2
(fr)
|
2002-12-19 |
2004-07-15 |
Merck & Co., Inc. |
Amides substitues
|
|
WO2004058727A1
(fr)
|
2002-12-20 |
2004-07-15 |
Bayer Pharmaceuticals Corporation |
3,5-dihydro-4-h-imidazol-4-ones substitues utilises dans le traitement de l'obesite
|
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
|
FR2849032B1
(fr)
|
2002-12-23 |
2006-04-28 |
Sanofi Synthelabo |
Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
|
|
WO2004056744A1
(fr)
|
2002-12-23 |
2004-07-08 |
Janssen Pharmaceutica N.V. |
Adamantyl acetamides utilises comme inhibiteurs de la hydroxysteroide deshydrogenase
|
|
GB0230087D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
GB0230088D0
(en)
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2004063179A1
(fr)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Arylcyclopropylacetamides substitues servant d'activateurs de glucokinase
|
|
RS20050532A
(sr)
|
2003-01-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
|
|
TW200503994A
(en)
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
|
US7176210B2
(en)
|
2003-02-10 |
2007-02-13 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
JP4621198B2
(ja)
|
2003-02-11 |
2011-01-26 |
プロシディオン・リミテッド |
トリ(シクロ)置換アミドグルコキナーゼ活性化化合物
|
|
PL378117A1
(pl)
|
2003-02-11 |
2006-03-06 |
Prosidion Limited |
Tricyklopodstawione związki amidowe
|
|
AU2004212043A1
(en)
|
2003-02-13 |
2004-08-26 |
Sanofi-Aventis Deutschland Gmbh |
Nitrogen-substituted hexahydropyrazino(1,2-a)pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments
|
|
ATE472548T1
(de)
|
2003-02-13 |
2010-07-15 |
Sanofi Aventis Deutschland |
Substituierte hexahydro-pyrazino(1,2-a)pyrimidin- 4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1599477B1
(fr)
|
2003-02-19 |
2008-01-30 |
F. Hoffmann-La Roche Ag |
Derives de xanthine substitues par des sulfonamides et utiles comme inhibiteurs de pepck
|
|
US7160886B2
(en)
|
2003-03-03 |
2007-01-09 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
|
EP1460069A1
(fr)
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Dérivés substitués du cyclohexane et de la pipéridine comme modulateurs du récepteur de la melanocortine-4
|
|
EP1460075A1
(fr)
|
2003-03-21 |
2004-09-22 |
Sanofi-Synthelabo |
Derivées substituées de 8-perfluoro-6,7,8,9-tetrahydropyrimido[1,2a]pyrimidin-4-one
|
|
US20040185559A1
(en)
|
2003-03-21 |
2004-09-23 |
Isis Pharmaceuticals Inc. |
Modulation of diacylglycerol acyltransferase 1 expression
|
|
RU2345985C2
(ru)
|
2003-03-26 |
2009-02-10 |
Актелион Фармасьютиклз Лтд. |
Производные тетрагидроизохинолилацетамида в качестве антагонистов орексинового рецептора
|
|
ATE474577T1
(de)
|
2003-03-26 |
2010-08-15 |
Merck Sharp & Dohme |
Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
|
|
DE10314610A1
(de)
|
2003-04-01 |
2004-11-04 |
Aventis Pharma Deutschland Gmbh |
Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung
|
|
ATE455547T1
(de)
|
2003-04-11 |
2010-02-15 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1, 2,4-triazolen
|
|
WO2004089367A1
(fr)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Utilisation pharmaceutique de 1,2,4-triazoles substituees
|
|
DE602004027171D1
(de)
|
2003-04-11 |
2010-06-24 |
High Point Pharmaceuticals Llc |
Verbindungen mit Aktivität an der 11Beta-Hydroxasteroiddehydrogenase
|
|
US20060194871A1
(en)
|
2003-04-11 |
2006-08-31 |
Barvian Kevin K |
Heterocyclic mchr1 antagoists
|
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
US7268133B2
(en)
|
2003-04-23 |
2007-09-11 |
Pfizer, Inc. Patent Department |
Cannabinoid receptor ligands and uses thereof
|
|
US20040214856A1
(en)
|
2003-04-23 |
2004-10-28 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
|
CN100472485C
(zh)
|
2003-04-25 |
2009-03-25 |
松下电器产业株式会社 |
服务器及服务器的处理方法
|
|
AU2004234125A1
(en)
|
2003-05-01 |
2004-11-11 |
Vernalis Research Limited |
Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
|
|
US20060276452A1
(en)
|
2003-05-01 |
2006-12-07 |
Vernalis Research Limited |
Use of azetidinecarboxamide derivatives in therapy
|
|
EP1618105A1
(fr)
|
2003-05-01 |
2006-01-25 |
Vernalis Research Limited |
Derives azetidinecarboxamide et leur utilisation pour le traitement de troubles a mediation du recepteur du cb1
|
|
CA2524397A1
(fr)
|
2003-05-07 |
2004-11-18 |
Pfizer Products Inc. |
Ligands de recepteurs cannabinoides et leurs applications
|
|
AU2004238240A1
(en)
|
2003-05-09 |
2004-11-25 |
Merck & Co., Inc. |
Benzimidazoles, compositions containing such compounds and methods of use
|
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
|
US7067529B2
(en)
|
2003-05-19 |
2006-06-27 |
Hoffmann-La Roche Inc. |
Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors
|
|
AU2004240885A1
(en)
|
2003-05-21 |
2004-12-02 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I
|
|
EP1651229A1
(fr)
|
2003-05-23 |
2006-05-03 |
Chiron Corporation |
Composes de quinazoline substitues par guanidino constituant des agonistes de mc4-r
|
|
ATE476425T1
(de)
|
2003-05-29 |
2010-08-15 |
Merck Sharp & Dohme |
Triazolderivate als inhibitoren von 11-beta- hydroxysteroid-dehydrogenase-1
|
|
WO2004106343A2
(fr)
|
2003-05-30 |
2004-12-09 |
Ufc Limited |
Molecules et analogues de la famille agelastatine d'alkaloides antitumuraux et inhibiteurs de gsk-3?
|
|
JP2004359630A
(ja)
|
2003-06-06 |
2004-12-24 |
Yamanouchi Pharmaceut Co Ltd |
ジフルオロジフェニルメタン誘導体及びその塩
|
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
KR20060019587A
(ko)
|
2003-06-11 |
2006-03-03 |
머크 앤드 캄파니 인코포레이티드 |
치환된 3-알킬 및 3-알케닐 아제티딘 유도체
|
|
US7439363B2
(en)
|
2003-06-13 |
2008-10-21 |
Janssen Parmaceutica N.V. |
Substituted indazoly(indoly)maleimide derivatives as kinase inhibitors
|
|
EP1641779A1
(fr)
|
2003-06-18 |
2006-04-05 |
AstraZeneca AB |
Derives de 5,6-diaryl-pyrazine substitués en position 2 comme modulateurs cb1
|
|
US20040259887A1
(en)
|
2003-06-18 |
2004-12-23 |
Pfizer Inc |
Cannabinoid receptor ligands and uses thereof
|
|
EA200600055A1
(ru)
|
2003-06-19 |
2006-08-25 |
Эли Лилли Энд Компани |
Агонисты рецептора меланокортина 4 (мк4 ) и их применение
|
|
BRPI0411699A
(pt)
|
2003-06-20 |
2006-08-29 |
Hoffmannn La Roche Ag F |
compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
|
|
SE0301888D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use VII
|
|
FR2856683A1
(fr)
|
2003-06-25 |
2004-12-31 |
Sanofi Synthelabo |
Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application en therapeutique
|
|
WO2004113310A1
(fr)
|
2003-06-25 |
2004-12-29 |
Biovitrum Ab |
Utilisation d'un inhibiteur de compose de type 1 11-b-hydroxysteroide deshydrogenase type 1 destine a faciliter la cicatrisation d'une plaie
|
|
SE0301882D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use I
|
|
SE0301886D0
(sv)
|
2003-06-25 |
2003-06-25 |
Biovitrum Ab |
New use V
|
|
WO2005000974A2
(fr)
|
2003-06-27 |
2005-01-06 |
Day-Glo Color Corp. |
Composition de marquage a pulveriser a base d'eau
|
|
CN100555588C
(zh)
|
2003-06-27 |
2009-10-28 |
日本电气株式会社 |
薄膜晶体管、薄膜晶体管基板、电子设备及多晶半导体薄膜的制造方法
|
|
JP2005015434A
(ja)
|
2003-06-27 |
2005-01-20 |
Kotobuki Seiyaku Kk |
血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
|
|
DE10331074A1
(de)
|
2003-07-09 |
2005-02-03 |
Conti Temic Microelectronic Gmbh |
Sensoranordnung zur Abstands- und/oder Geschwindigkeitsmessung
|
|
MXPA06000326A
(es)
|
2003-07-09 |
2006-03-30 |
Forbes Medi Tech Inc |
Novedosos compuestos y composiciones que contienen esteroles y/o estanoles e inhibidores de biosintesis de colesterol, y su uso en el tratamiento o prevencion de una variedad de enfermedades y condiciones.
|
|
WO2005007628A1
(fr)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Derives de tetrahydroquinoleine constituant des modulateurs des recepteurs des cannabinoides
|
|
EP1644411A2
(fr)
|
2003-07-11 |
2006-04-12 |
Novo Nordisk A/S |
Compositions d'insuline stabilisee
|
|
FR2857570A1
(fr)
|
2003-07-18 |
2005-01-21 |
Didier Leandri |
Dispositif de suspension de verres a pied autour d'un seau utilisable pour le rafraichissement des boissons
|
|
CN1826116A
(zh)
|
2003-07-22 |
2006-08-30 |
麦克公司 |
作为黑皮素-4受体激动剂的哌啶衍生物
|
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
|
DE10334309A1
(de)
|
2003-07-28 |
2005-03-03 |
Aventis Pharma Deutschland Gmbh |
Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
EP1653949A4
(fr)
|
2003-08-07 |
2009-04-22 |
Merck & Co Inc |
Carboxamides de pyrazole utilises comme inhibiteurs de la dehydrogenase-1 11-beta-hydroxysteroide
|
|
WO2005013907A2
(fr)
|
2003-08-07 |
2005-02-17 |
Japan Tobacco Inc. |
Derives de pyrrolo[1,2-b]pyridazine
|
|
TW200510324A
(en)
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
|
CA2534428A1
(fr)
|
2003-08-13 |
2005-03-03 |
Paul A. Tempest |
Antagonistes du recepteur de l'hormone concentrant la melanine
|
|
US7326706B2
(en)
|
2003-08-15 |
2008-02-05 |
Bristol-Myers Squibb Company |
Pyrazine modulators of cannabinoid receptors
|
|
US20070072812A1
(en)
|
2003-08-25 |
2007-03-29 |
Microbia, Inc. |
Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
|
|
US20070161577A1
(en)
|
2003-08-28 |
2007-07-12 |
Martinez Eduardo J |
Tethered dimers and trimers of 1,4-diphenylazetidin-2-ones
|
|
JP2007521322A
(ja)
|
2003-09-18 |
2007-08-02 |
メルク エンド カムパニー インコーポレーテッド |
置換スルホンアミド類
|
|
AR045651A1
(es)
|
2003-09-19 |
2005-11-02 |
Solvay Pharm Bv |
Derivados de tiazol como moduladores del receptor de cannabinoide
|
|
EP1670515A2
(fr)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Derives de peptides therapeutiques liant l'albumine
|
|
US20050070712A1
(en)
|
2003-09-26 |
2005-03-31 |
Christi Kosogof |
Pyrimidine derivatives as ghrelin receptor modulators
|
|
JP2007532471A
(ja)
|
2003-09-30 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
新規メラノコルチンレセプターアゴニスト
|
|
EP1522541A1
(fr)
|
2003-10-07 |
2005-04-13 |
Lipideon Biotechnology AG |
Nouveaux composés hypocholesterolémiques
|
|
US7244843B2
(en)
|
2003-10-07 |
2007-07-17 |
Bristol-Myers Squibb Company |
Modulators of serotonin receptors
|
|
US20050119252A1
(en)
|
2003-10-22 |
2005-06-02 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
GB0325192D0
(en)
|
2003-10-29 |
2003-12-03 |
Astrazeneca Ab |
Method of use
|
|
EP1682117A1
(fr)
|
2003-10-30 |
2006-07-26 |
Merck & Co., Inc. |
Composes de 2-azetidinones utilises comme agents pour lutter contre une hypercholesterolemie
|
|
GB0325402D0
(en)
|
2003-10-31 |
2003-12-03 |
Astrazeneca Ab |
Compounds
|
|
WO2005042692A2
(fr)
|
2003-10-31 |
2005-05-12 |
Forbes Medi-Tech Inc. |
Methode permettant d'inhiber l'expression de genes qui induisent l'influx de cholesterol cellulaire dans les cellules animales et d'inhiber la production de proteines issues de l'expression de ces genes
|
|
ATE372995T1
(de)
|
2003-11-07 |
2007-09-15 |
Hoffmann La Roche |
Benzo(b)(1,4)dioxepinderivate
|
|
DE602004008100T2
(de)
|
2003-11-10 |
2008-04-30 |
Microbia Inc., Cambridge |
4-biarylyl-1-phenylazetidin-2-one
|
|
KR20050045927A
(ko)
|
2003-11-12 |
2005-05-17 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
|
TWI341835B
(en)
|
2003-11-12 |
2011-05-11 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
|
US7368453B2
(en)
|
2003-11-19 |
2008-05-06 |
Chiron Corporation |
Quinazolinone compounds with reduced bioaccumulation
|
|
EP1538159A1
(fr)
|
2003-12-05 |
2005-06-08 |
Santhera Pharmaceuticals (Schweiz) GmbH |
Dérivés de N-benzyl-lactam comme agonistes du récepteur melanocortine-4
|
|
WO2005060985A1
(fr)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition volontaire de consommation d'ethanol au moyen d'agonistes du recepteur 4 de la melanocortine
|
|
DE10359098A1
(de)
|
2003-12-17 |
2005-07-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-(Piperazin-1-yl)- und 2-([1,4]Diazepan-1-yl)-imidazo[4,5-d]pyridazin-4-one, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7301036B2
(en)
|
2003-12-19 |
2007-11-27 |
Merck & Co., Inc. |
Cyclic guanidines, compositions containing such compounds and methods of use
|
|
TW200528455A
(en)
|
2003-12-19 |
2005-09-01 |
Bristol Myers Squibb Co |
Azabicyclic heterocycles as cannabinoid receptor modulators
|
|
KR20060127886A
(ko)
|
2003-12-19 |
2006-12-13 |
바이오비트럼 에이비 |
5-ht6 수용체-관련 장애의 예방 및 치료에 사용될 수있는, 신규한 벤조퓨란 유도체
|
|
HRP20070241T3
(hr)
|
2003-12-19 |
2007-07-31 |
Bristol-Myers Squibb Company |
Azabiciklički heterocikli kao modulatori kanabinoid receptora
|
|
EP1557417B1
(fr)
|
2003-12-19 |
2007-03-07 |
Sanofi-Aventis |
Dérivés de 8'-pyri(mi)dinyl-dihydrospiro-[cycloaklyamine]-pyrimido[1,2-a]pyrimidin-6-one substitués
|
|
ATE485267T1
(de)
|
2003-12-23 |
2010-11-15 |
Astrazeneca Ab |
Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
|
|
GB0329778D0
(en)
|
2003-12-23 |
2004-01-28 |
Astrazeneca Ab |
Chemical compounds
|
|
JP2007516287A
(ja)
|
2003-12-23 |
2007-06-21 |
メルク エンド カムパニー インコーポレーテッド |
抗高コレステロール血症化合物
|
|
US8207147B2
(en)
|
2003-12-24 |
2012-06-26 |
Prosidion Limited |
Heterocyclic derivatives as GPCR receptor agonists
|
|
WO2005067932A1
(fr)
|
2004-01-06 |
2005-07-28 |
Janssen Pharmaceutica, N.V. |
Derives de (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino)-benzamide et composes afferents comme inhibiteurs de la glycogene phosphorylase dans le traitement du diabete et de l'obesite
|
|
JP2005206492A
(ja)
|
2004-01-21 |
2005-08-04 |
Sankyo Co Ltd |
スルホンアミド化合物
|
|
DE102004003812A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE102004003811A1
(de)
|
2004-01-25 |
2005-08-11 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2005075450A2
(fr)
|
2004-01-28 |
2005-08-18 |
F. Hoffmann-La Roche Ag |
Nouveaux composes spiro-pentacycliques
|
|
AU2005209115A1
(en)
|
2004-01-30 |
2005-08-11 |
Japan Tobacco Inc. |
Anorectic compounds
|
|
JP2007519648A
(ja)
|
2004-01-31 |
2007-07-19 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
7−フェニルアミノ−4−キノロン−3−カルボン酸誘導体、その製造方法及び医薬としての使用
|
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
|
HUP0400405A3
(en)
|
2004-02-10 |
2009-03-30 |
Sanofi Synthelabo |
Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
|
|
DE102004006325A1
(de)
|
2004-02-10 |
2005-08-25 |
Bayer Healthcare Ag |
Tetrahydrobenzo[d]azepin-2-on-Derivate und ihre Verwendung
|
|
FR2866340B1
(fr)
|
2004-02-13 |
2006-11-24 |
Sanofi Synthelabo |
Derives d'oxazole, leur preparation et leur utilisation en therapeutique.
|
|
EP1718609A1
(fr)
|
2004-02-17 |
2006-11-08 |
Laboratorios Del Dr. Esteve, S.A. |
Composes d'azetidine substitues, preparation et utilisation comme medicaments
|
|
JP2007523905A
(ja)
|
2004-02-18 |
2007-08-23 |
アストラゼネカ アクチボラグ |
化合物
|
|
AU2005214084B2
(en)
|
2004-02-19 |
2010-06-03 |
Solvay Pharmaceuticals B.V. |
Imidazoline derivatives having CB1-antagonistic activity
|
|
US20090149463A1
(en)
|
2004-02-20 |
2009-06-11 |
Leifeng Cheng |
Therapeutic agents
|
|
GB0403780D0
(en)
|
2004-02-20 |
2004-03-24 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1718671A2
(fr)
|
2004-02-23 |
2006-11-08 |
Rheoscience A/S |
Analogues du peptide yy
|
|
CA2556390C
(fr)
|
2004-02-25 |
2012-10-02 |
Eli Lilly And Company |
2,3,4,5-tetrahydro-1h-benzo[d]azepines substitues en position 6 en tant qu'agonistes de recepteur 5-ht<sb>2c</sb>
|
|
US7902191B2
(en)
|
2004-02-25 |
2011-03-08 |
Eli Lilly And Company |
Histamine H3 receptor antagonists, preparation and therapeutic uses
|
|
DE102004010194A1
(de)
|
2004-03-02 |
2005-10-13 |
Aventis Pharma Deutschland Gmbh |
4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
|
|
AU2005219779B2
(en)
|
2004-03-04 |
2011-04-14 |
Kissei Pharmaceutical Co., Ltd. |
Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
|
|
US7732456B2
(en)
|
2004-03-05 |
2010-06-08 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone derivative
|
|
WO2005085226A1
(fr)
|
2004-03-10 |
2005-09-15 |
Janssen Pharmaceutica N.V. |
Piperidines d'aryle ou piperazines substituees par des heterocycles a 5 ramifications inhibant la mtp
|
|
DE102004012068A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue alkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
GB0406378D0
(en)
|
2004-03-22 |
2004-04-21 |
Karobio Ab |
Novel pharmaceutical compositions
|
|
WO2005097759A1
(fr)
|
2004-03-29 |
2005-10-20 |
Merck & Co., Inc. |
Utilisation de diaryltriazoles comme inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase-1
|
|
EP1586318A1
(fr)
|
2004-04-05 |
2005-10-19 |
Neuropharma S.A.U. |
Thiazolidinones comme inhibiteurs de GSK-3
|
|
WO2005097129A2
(fr)
|
2004-04-05 |
2005-10-20 |
Takeda Pharmaceutical Company Limited |
Compose de 6-azaindole
|
|
WO2005097738A1
(fr)
|
2004-04-06 |
2005-10-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
Nouveau derive sulfonamide
|
|
EP1734930A2
(fr)
|
2004-04-09 |
2006-12-27 |
Smithkline Beecham Corporation |
Produits pharmaceutiques a faibles doses
|
|
FR2868780B1
(fr)
|
2004-04-13 |
2008-10-17 |
Sanofi Synthelabo |
Derives de la 1-amino-phthalazine, leur preparation et leur application en therapeutique
|
|
WO2005108370A1
(fr)
|
2004-04-16 |
2005-11-17 |
Ajinomoto Co., Inc. |
Composés du benzène
|
|
GEP20094723B
(en)
|
2004-05-25 |
2009-07-10 |
Pfizer Prod Inc |
Tetraazabenzo [e] azulene derivatives and analogs thereof
|
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
|
DE102004026532A1
(de)
|
2004-05-29 |
2006-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
DE102004028241B4
(de)
|
2004-06-11 |
2007-09-13 |
Sanofi-Aventis Deutschland Gmbh |
Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
|
|
FR2871463B1
(fr)
|
2004-06-11 |
2006-09-22 |
Merck Sante Soc Par Actions Si |
Derives a structure aroyl-o-piperidine, leurs procedes de preparation, les compositions pharmaceutiques qui les contiennent et leurs applications en therapeutique
|
|
AU2005257303A1
(en)
|
2004-06-24 |
2006-01-05 |
Shionogi & Co., Ltd. |
Sulfonamide compound
|
|
CA2570694A1
(fr)
|
2004-06-24 |
2006-02-02 |
Incyte Corporation |
Composes amido et utilisations de ces derniers en tant que produits pharmaceutiques
|
|
MXPA06014573A
(es)
|
2004-06-24 |
2007-03-12 |
Incyte Corp |
Compuestos amido y su uso como farmaceuticos.
|
|
US20080269284A1
(en)
|
2004-06-24 |
2008-10-30 |
Eli Lilly And Company |
Compounds and Methods for Treating Dyslipidemia
|
|
CA2572874A1
(fr)
|
2004-07-02 |
2006-01-12 |
Sankyo Company Limited |
Derive d'uree
|
|
WO2006017257A2
(fr)
|
2004-07-12 |
2006-02-16 |
Phenomix Corporation |
Derives d'acetidinone
|
|
FR2873368B1
(fr)
|
2004-07-26 |
2008-01-04 |
Merck Sante Soc Par Actions Si |
Derives de guanidine et leurs utilisations en therapeutique
|
|
GB0416728D0
(en)
|
2004-07-27 |
2004-09-01 |
7Tm Pharma As |
Medicinal use of receptor ligands
|
|
FR2873694B1
(fr)
|
2004-07-27 |
2006-12-08 |
Merck Sante Soc Par Actions Si |
Nouveaux aza-indoles inhibiteurs de la mtp et apob
|
|
EP1789041B1
(fr)
|
2004-07-28 |
2008-07-09 |
F. Hoffmann-Roche AG |
Derives d'aryl-pyridine comme inhibiteurs de la 11-beta-h5d1
|
|
FR2873690B1
(fr)
|
2004-07-29 |
2006-10-13 |
Sanofi Synthelabo |
Derives d'oxopiperidine, leur preparation et leur application en therapeutique
|
|
JP2008509146A
(ja)
|
2004-08-06 |
2008-03-27 |
メルク エンド カムパニー インコーポレーテッド |
11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのスルホニル化合物
|
|
WO2006018150A1
(fr)
|
2004-08-11 |
2006-02-23 |
Boehringer Ingelheim International Gmbh |
Cycles a substitution d-xylopyranosyl-phenyle, medicaments contenant ces composes, leur utilisation, et leur procede de production
|
|
MX2007001650A
(es)
|
2004-08-12 |
2007-07-13 |
Prosidion Ltd |
Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
|
|
WO2006019020A1
(fr)
|
2004-08-16 |
2006-02-23 |
Sankyo Company, Limited |
Urées de substitution
|
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1778250A2
(fr)
|
2004-08-18 |
2007-05-02 |
Metabasis Therapeutics, Inc. |
Nouveaux inhibiteurs thiazole de la fructose 1,6-bisphosphatase
|
|
CN101300005B
(zh)
|
2004-08-30 |
2013-05-01 |
詹森药业有限公司 |
作为11-β羟类固醇脱氢酶抑制剂的N-2金刚烷基-2-苯氧基-乙酰胺衍生物
|
|
CN101018790A
(zh)
|
2004-09-11 |
2007-08-15 |
塞诺菲-安万特德国有限公司 |
7-氮杂吲哚以及其用作ppar激动剂的应用
|
|
WO2006058064A2
(fr)
|
2004-11-29 |
2006-06-01 |
Merck & Co., Inc. |
Aminopiperidines fusionnees utilisees comme inhibiteurs de la dipeptidyle peptidase-iv permettant de traiter ou de prevenir le diabete
|
|
CA2581922A1
(fr)
|
2004-09-29 |
2006-04-06 |
Kissei Pharmaceutical Co., Ltd. |
Compose heterocyclique azote 1-(.beta.-d-glycopyranosyl)-3-substitue, preparation therapeutique contenant ledit compose, et emploi medical dudit compose
|
|
BRPI0515931A
(pt)
|
2004-09-29 |
2008-08-12 |
Hoffmann La Roche |
compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades e utilização desses compostos
|
|
US7884104B2
(en)
|
2004-10-01 |
2011-02-08 |
Merck Sharp & Dohme Corp. |
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
CA2582327A1
(fr)
|
2004-10-01 |
2006-04-13 |
Takao Suzuki |
Compose heterocyclique azote substitue en 2 par un groupement arylcarboxamide
|
|
JP5107713B2
(ja)
|
2004-10-07 |
2012-12-26 |
ノヴォ ノルディスク アー/エス |
遅延性のエキセンディン−4化合物
|
|
JP2008515856A
(ja)
|
2004-10-07 |
2008-05-15 |
ノボ ノルディスク アクティーゼルスカブ |
遅延性glp−1化合物
|
|
US7550467B2
(en)
|
2004-10-12 |
2009-06-23 |
Schering Corporation |
Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
|
|
EP1802623A1
(fr)
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
Composes spiro actifs du type a- hydroxysteroide deshydrogenase de type 1
|
|
WO2006044174A2
(fr)
|
2004-10-13 |
2006-04-27 |
Neurogen Corporation |
Composes de 8-azabicyclo[3.2.1]octane a substitution aryle comme ligands du recepteur de l'hormone de concentration de la melanine
|
|
JP2006111553A
(ja)
|
2004-10-13 |
2006-04-27 |
Dainippon Sumitomo Pharma Co Ltd |
スルホニルオキシインドール誘導体及びそれを含有する医薬組成物
|
|
WO2006045564A1
(fr)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Derives de xanthine avec activite du recepteur hm74a
|
|
WO2006045565A1
(fr)
|
2004-10-22 |
2006-05-04 |
Smithkline Beecham Corporation |
Derives de xanthine a activite de recepteur hm74a
|
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
|
WO2006049952A1
(fr)
|
2004-10-29 |
2006-05-11 |
Eli Lilly And Company |
Inhibiteurs de la 11-béta-hydroxystéroïde déshydrogénase 1 dérivés de cycloalkyllactames
|
|
EP1812407A2
(fr)
|
2004-11-02 |
2007-08-01 |
Pfizer, Inc. |
Nouveaux composes d'adamantyl amides substitues ou non
|
|
JP2006131559A
(ja)
|
2004-11-05 |
2006-05-25 |
Takeda Chem Ind Ltd |
含窒素複素環化合物
|
|
EP1666467A1
(fr)
|
2004-11-08 |
2006-06-07 |
Evotec AG |
Inhibiteurs de 11-béta-HSD1
|
|
EP1659113A1
(fr)
|
2004-11-08 |
2006-05-24 |
Evotec AG |
Inhibiteurs de 11 beta hydroxy stéroid dehydrogenase type 1 (11beta-HSD1)
|
|
WO2006051662A1
(fr)
|
2004-11-09 |
2006-05-18 |
Taisho Pharmaceutical Co., Ltd. |
Derive de thiazole
|
|
JP2006160733A
(ja)
|
2004-11-15 |
2006-06-22 |
Taisho Pharmaceut Co Ltd |
シアノフルオロピロリジン誘導体を有効成分として含有する医薬
|
|
WO2006059744A1
(fr)
|
2004-11-30 |
2006-06-08 |
Nippon Chemiphar Co., Ltd. |
ACTIVANT DE RÉCEPTEUR δ ACTIVÉ PAR UN PROLIFÉRATEUR DE PEROXISOME
|
|
US7700597B2
(en)
|
2004-12-03 |
2010-04-20 |
Schering Corporation |
Substituted piperazines as CB1 antagonists
|
|
AU2005311269B2
(en)
|
2004-12-03 |
2011-11-10 |
Transtech Pharma, Inc. |
Heteroaromatic glucokinase activators
|
|
DE102004058449A1
(de)
|
2004-12-03 |
2006-06-14 |
Merck Patent Gmbh |
Tetrahydropyranderivate
|
|
JP2008007405A
(ja)
|
2004-12-07 |
2008-01-17 |
Takeda Chem Ind Ltd |
カルボキサミド誘導体
|
|
BRPI0519058A2
(pt)
|
2004-12-14 |
2008-12-23 |
Astrazeneca Ab |
composto ou um sal prà-droga farmaceuticamente aceitÁvel do mesmo, mÉtodos para produzir uma inibiÇço da atividade de dgat1 e para tratar diabete melito e/ou obesidade em um animal de sangue quente, uso de um composto, composiÇço farmacÊutica, e, processo para preparar um composto
|
|
WO2006065826A2
(fr)
|
2004-12-15 |
2006-06-22 |
Merck & Co., Inc. |
Procede de preparation de derives de beta-aminoacides chiraux par hydrogenation asymetrique
|
|
DE102004060542A1
(de)
|
2004-12-16 |
2006-07-06 |
Sanofi-Aventis Deutschland Gmbh |
Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
WO2006066109A2
(fr)
|
2004-12-17 |
2006-06-22 |
Takeda San Diego, Inc. |
Inhibiteurs des hydroxysteroides deshydrogenases
|
|
EP1828136A1
(fr)
|
2004-12-18 |
2007-09-05 |
Bayer HealthCare AG |
Derives de (5s)-3-[(s)-fluor(4-trifluoromethylphenyl)methyl]-5,6,7,8-tetrahydroquinolein-5-ol, et leur utilisation en tant qu'inhibiteurs de la proteine de transfert des esters de cholesterol (cetp)
|
|
JP2006176443A
(ja)
|
2004-12-22 |
2006-07-06 |
Shionogi & Co Ltd |
メラニン凝集ホルモン受容体アンタゴニスト
|
|
JP2008525401A
(ja)
|
2004-12-23 |
2008-07-17 |
アストラゼネカ アクチボラグ |
治療薬
|
|
PE20060949A1
(es)
|
2004-12-23 |
2006-10-11 |
Arena Pharm Inc |
Derivados fusionados de pirazol como agonistas del receptor de niacina
|
|
EP1831177A1
(fr)
|
2004-12-23 |
2007-09-12 |
AstraZeneca AB |
Agents therapeutiques
|
|
WO2006067224A2
(fr)
|
2004-12-23 |
2006-06-29 |
Biovitrum Ab (Publ) |
Nouveaux composes
|
|
KR20070090206A
(ko)
|
2004-12-24 |
2007-09-05 |
다이닛본 스미토모 세이야꾸 가부시끼가이샤 |
2환식 피롤 유도체
|
|
KR20070091038A
(ko)
|
2004-12-24 |
2007-09-06 |
프로시디온 리미티드 |
G-단백질 결합 수용체(gpr116) 효능제 및 비만 및당뇨병을 치료하기 위한 이의 용도
|
|
EP1838706A1
(fr)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
Agonistes du récepteur couplé aux protéines g
|
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
MX2007007919A
(es)
|
2004-12-31 |
2008-01-22 |
Reddy Us Therapeutics Inc |
Nuevos derivados de bencilaminas como inhibidores de la proteina de transferencia de colesteril-ester(cetp).
|
|
DE102005000666B3
(de)
|
2005-01-04 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
KR101496190B1
(ko)
|
2005-01-05 |
2015-02-26 |
애브비 인코포레이티드 |
11-베타-하이드록시스테로이드 데하이드로게나제 타입 1 효소의 억제제로서의 아다만틸 유도체
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
WO2006073167A1
(fr)
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
Derives de la pyrrolidine
|
|
DE102005001053A1
(de)
|
2005-01-07 |
2006-07-20 |
Merck Patent Gmbh |
Quadratsäurederivate
|
|
DE102005002130A1
(de)
|
2005-01-17 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
|
|
CN101107235B
(zh)
|
2005-01-18 |
2011-03-16 |
霍夫曼-拉罗奇有限公司 |
作为5-ht2c激动剂的吗啉类化合物
|
|
AU2006206573B9
(en)
|
2005-01-19 |
2011-09-29 |
Merck Sharp & Dohme Corp. |
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
JP2008100916A
(ja)
|
2005-01-24 |
2008-05-01 |
Dainippon Sumitomo Pharma Co Ltd |
インドール類およびそれを含む医薬組成物
|
|
AR053329A1
(es)
|
2005-01-31 |
2007-05-02 |
Tanabe Seiyaku Co |
Derivados de indol utiles como inhibidores de los transportadores de glucosa dependientes del sodio (sglt)
|
|
WO2006082952A1
(fr)
|
2005-02-01 |
2006-08-10 |
Takeda Pharmaceutical Company Limited |
Composé amide
|
|
CN101141957A
(zh)
|
2005-02-03 |
2008-03-12 |
Irm责任有限公司 |
作为ppar调节剂的化合物和组合物
|
|
EP1851197A2
(fr)
|
2005-02-09 |
2007-11-07 |
Microbia, Inc. |
Derives de phenylazetidinone
|
|
US20080227792A1
(en)
|
2005-02-15 |
2008-09-18 |
Novo Nordisk A/S |
3,4-Dihydro-1H-Isoquinoline-2-Carboxylic Acid 5-Aminopyridin-2-Yl Esters
|
|
US7749972B2
(en)
|
2005-02-15 |
2010-07-06 |
Kissei Pharmaceutical Co., Ltd. |
1-substituted-7-(β-D-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same
|
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
|
FR2882365B1
(fr)
|
2005-02-21 |
2007-09-07 |
Sanofi Aventis Sa |
Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
|
|
ZA200708144B
(en)
|
2005-02-25 |
2008-11-26 |
Takeda Pharmaceutical |
Pyridyl acetic acid compounds
|
|
WO2006096847A1
(fr)
|
2005-03-09 |
2006-09-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
L'obestatine et ses applications
|
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
FR2883000B1
(fr)
|
2005-03-14 |
2007-06-01 |
Merck Sante Soc Par Actions Si |
Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
|
|
DE102005012874A1
(de)
|
2005-03-19 |
2006-09-21 |
Sanofi-Aventis Deutschland Gmbh |
Amid substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE102005012873B4
(de)
|
2005-03-19 |
2007-05-03 |
Sanofi-Aventis Deutschland Gmbh |
Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
TW200700387A
(en)
|
2005-03-21 |
2007-01-01 |
Akzo Nobel Nv |
1-benzylindole-2-carboxamide derivatives
|
|
US20090186834A1
(en)
|
2005-03-24 |
2009-07-23 |
Microbia, Inc. |
Diphenylheterocycle cholesterol absorption inhibitors
|
|
WO2006104030A1
(fr)
|
2005-03-25 |
2006-10-05 |
Daiichi Sankyo Company, Limited |
Compose thiazole
|
|
NZ560917A
(en)
|
2005-03-31 |
2011-01-28 |
Pfizer Prod Inc |
Cyclopentapyridine and tetrahydroquinoline derivatives
|
|
CN101151244B
(zh)
|
2005-04-01 |
2014-09-03 |
伊莱利利公司 |
组胺h3受体活性剂、制备和治疗用途
|
|
TWI357902B
(en)
|
2005-04-01 |
2012-02-11 |
Lg Life Science Ltd |
Dipeptidyl peptidase-iv inhibiting compounds, meth
|
|
ES2326280T3
(es)
|
2005-04-06 |
2009-10-06 |
F. Hoffmann-La Roche Ag |
Derivados de piridin-3-carboxamida como agonistas inversos de cb1.
|
|
WO2006106423A2
(fr)
|
2005-04-07 |
2006-10-12 |
Pfizer Inc. |
Nouveaux composes de derives aminosulfonyles
|
|
EP1874301A4
(fr)
|
2005-04-13 |
2009-05-06 |
Merck & Co Inc |
Agonistes du recepteur de la niacine, compositions les contenant et methodes de traitement
|
|
WO2006108842A1
(fr)
|
2005-04-15 |
2006-10-19 |
Boehringer Ingelheim International Gmbh |
Derives de glucopyranosyl-substitue (heteroaryloxy-benzyl)-benzene utilises comme inhibiteurs de sglt
|
|
DE102005017605B4
(de)
|
2005-04-16 |
2007-03-15 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte 2-Aminoalkylthio-benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1871762A2
(fr)
|
2005-04-18 |
2008-01-02 |
Neurogen Corporation |
Antagonistes cb1 heteroaryle substitue
|
|
MX2007013049A
(es)
|
2005-04-19 |
2008-01-11 |
Bayer Pharmaceuticals Corp |
Preparacion y uso de derivados de aril alquil acido para el tratamiento de la obesidad.
|
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
|
DE102005018389A1
(de)
|
2005-04-20 |
2006-10-26 |
Sanofi-Aventis Deutschland Gmbh |
Azolderivate als Inhibitoren von Lipasen und Phospholipasen
|
|
CA2605479A1
(fr)
|
2005-04-20 |
2006-10-26 |
Pfizer Products Inc. |
Composes acylaminobicycliques comportant un heteroatome et leurs utilisations
|
|
US20080194494A1
(en)
|
2005-04-26 |
2008-08-14 |
Microbia, Inc. |
4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia
|
|
EP1876179B1
(fr)
|
2005-04-28 |
2015-03-25 |
Takeda Pharmaceutical Company Limited |
Composés de thiénopyrimidone
|
|
WO2006121861A2
(fr)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Inhibiteurs d'absorption de biphenylazetidinone cholesterol
|
|
CA2607566A1
(fr)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Agonistes vis-a-vis du recepteur peptidique de type glucagon 1 (glp-1) et procedes pharmacologiques d'utilisation
|
|
JP2008540485A
(ja)
|
2005-05-10 |
2008-11-20 |
エフ.ホフマン−ラ ロシュ アーゲー |
ジアシルグリセロールアシルトランスフェラーゼ阻害剤
|
|
FR2885627B3
(fr)
|
2005-05-10 |
2007-06-22 |
Espace Production Internationa |
Procede de fabrication de lames de revetement de sol et lames issues de ce procede, feuille decor pour panneaux de revetement de sol
|
|
EP1879860A2
(fr)
|
2005-05-10 |
2008-01-23 |
Microbia Inc. |
Derives de 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone utilises dans le traitement de l'hypercholesterolemie
|
|
AU2006244043A1
(en)
|
2005-05-11 |
2006-11-16 |
Microbia, Inc. |
Processes for production of phenolic 4-biphenylylazetidin-2-ones
|
|
SI1881850T1
(sl)
|
2005-05-13 |
2011-01-31 |
Lilly Co Eli |
Glp-1 pegilirane spojine
|
|
BRPI0610133A2
(pt)
|
2005-05-17 |
2010-06-01 |
Schering Corp |
heterociclos como agonistas de receptor de ácido nicotìnico para o tratamento de dislipidemia
|
|
WO2007046868A2
(fr)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Derives de thiazolidine et leurs utilisations en tant qu’agents therapeutiques
|
|
WO2007046867A2
(fr)
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Derives de piperidine et leurs utilisations comme agents therapeutiques
|
|
WO2007044085A2
(fr)
|
2005-05-19 |
2007-04-19 |
Xenon Pharmaceuticals Inc. |
Composes heteroaryle et leurs utilisations en tant qu'agents therapeutiques
|
|
US7906649B2
(en)
|
2005-05-25 |
2011-03-15 |
Merck Sharp & Dohme Corp. |
Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
|
|
EA200702614A1
(ru)
|
2005-05-25 |
2008-04-28 |
Майкробиа, Инк. |
Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот
|
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2610671A1
(fr)
|
2005-05-31 |
2006-12-07 |
Astrazeneca Ab |
Nouveaux antagonistes du mchr1 et leur utilisation dans le traitement des affections et des troubles induits par le mchr1
|
|
KR100970294B1
(ko)
|
2005-06-08 |
2010-07-15 |
니뽄 다바코 산교 가부시키가이샤 |
복소환 화합물
|
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
NZ564696A
(en)
|
2005-06-10 |
2011-05-27 |
Boehringer Ingelheim Int |
Glucocorticoid, indazole, mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
CA2610188A1
(fr)
|
2005-06-11 |
2006-12-21 |
Astrazeneca Ab |
Derives d'oxadiazole en tant qu'inhibiteurs de la diacylglycerol acyltransferase (dgat)
|
|
US7696177B2
(en)
|
2005-06-15 |
2010-04-13 |
Merck Sharp & Dohme Corp. |
Anti-hypercholesterolemic compounds
|
|
WO2006134481A1
(fr)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibiteurs de la 11-beta hydroxysteroide deshydrogenase de type 1
|
|
KR20080016649A
(ko)
|
2005-06-16 |
2008-02-21 |
화이자 인코포레이티드 |
N-(피리딘-2-일)-술폰아미드 유도체
|
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
|
WO2006133926A1
(fr)
|
2005-06-17 |
2006-12-21 |
Carex Sa |
Derives de pyrazole utilises comme modulateurs du recepteur cannabinoide
|
|
UY29607A1
(es)
|
2005-06-20 |
2007-01-31 |
Astrazeneca Ab |
Compuestos quimicos
|
|
AR057383A1
(es)
|
2005-06-22 |
2007-12-05 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
|
AR054482A1
(es)
|
2005-06-22 |
2007-06-27 |
Astrazeneca Ab |
Derivados de azetidinona para el tratamiento de hiperlipidemias
|
|
AR056866A1
(es)
|
2005-06-22 |
2007-10-31 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, una formulacion farmaceutica y un proceso de preparacion del compuesto
|
|
AR057380A1
(es)
|
2005-06-22 |
2007-11-28 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos
|
|
SA06270191B1
(ar)
|
2005-06-22 |
2010-03-29 |
استرازينيكا ايه بي |
مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
|
|
AR057072A1
(es)
|
2005-06-22 |
2007-11-14 |
Astrazeneca Ab |
Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
|
|
ES2353818T3
(es)
|
2005-06-22 |
2011-03-07 |
F. Hoffmann-La Roche Ag |
(6-fluor-benzo[1,3]dioxolil)-morfolin-4-il-metanonas y su uso como ligandos de cb1.
|
|
WO2007001939A1
(fr)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Composes tetrahydro-pyranopyrazole presentant des activites de modulation de cannabinoïde
|
|
WO2007000445A1
(fr)
|
2005-06-29 |
2007-01-04 |
Boehringer Ingelheim International Gmbh |
Derives de benzyle-benzene a substitution glucopyranosyle, medicaments contenant de tels composes, utilisation et production de ces derniers
|
|
US20090325924A1
(en)
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
|
JP2008545010A
(ja)
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Gタンパク質共役受容体アゴニスト
|
|
GB0513692D0
(en)
|
2005-07-04 |
2005-08-10 |
Karobio Ab |
Novel pharmaceutical compositions
|
|
JP4787321B2
(ja)
|
2005-07-05 |
2011-10-05 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピリダジン誘導体
|
|
JP2009500377A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー/エス |
ジシクロアルキルウレア型グルコキナーゼ活性化剤
|
|
WO2007007688A1
(fr)
|
2005-07-08 |
2007-01-18 |
Mochida Pharmaceutical Co., Ltd. |
Dérivé de 3,5-diamino-1,2,4-triazole
|
|
US20110053910A1
(en)
|
2005-07-09 |
2011-03-03 |
Mckerrecher Darren |
2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes
|
|
RU2420525C2
(ru)
|
2005-07-11 |
2011-06-10 |
Мицубиси Танабе Фарма Корпорейшн |
Производные оксимов и их получение
|
|
JP2007022943A
(ja)
|
2005-07-13 |
2007-02-01 |
Dai Ichi Seiyaku Co Ltd |
スクアレン合成酵素阻害薬
|
|
CA2614544C
(fr)
|
2005-07-13 |
2013-09-10 |
Banyu Pharmaceutical Co., Ltd. |
Derive du benzimidazole a substitution par un heterocycle
|
|
JP4960355B2
(ja)
|
2005-07-14 |
2012-06-27 |
ノボ・ノルデイスク・エー/エス |
ウレア型グルコキナーゼ活性化剤
|
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
|
WO2007009705A1
(fr)
|
2005-07-15 |
2007-01-25 |
Laboratorios Del Dr. Esteve, S.A. |
Hydrates de (rac) -n-piperidinyl-5- (4-chlorophenyl) -1- (2, 4-dichlorophenyl) -4, 5-dihydr0-1h-pyr azole-3 -carboxamide
|
|
EP1757587A1
(fr)
|
2005-07-15 |
2007-02-28 |
Laboratorios Del Dr. Esteve, S.A. |
Composés de pyrazoline substituée, leur préparation et leur usage comme médicaments
|
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
|
ES2326461B1
(es)
|
2005-07-15 |
2010-04-19 |
Laboratorios Del Dr. Esteve, S.A. |
Polimorfo de n-priperidinil-5-(4-clorofenil)-1-(2,4-dicloforenil)-4,5-dihidro-1h-pirazol-3-carboxamida y su uso como modulador de receptores de cannabinoides.
|
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
|
ATE509023T1
(de)
|
2005-07-19 |
2011-05-15 |
Merck Sharp & Dohme |
Spirochromanon-derivate als acetyl-koenzym-a- carboxylase-hemmer
|
|
WO2007009236A1
(fr)
|
2005-07-20 |
2007-01-25 |
Merck Frosst Canada Ltd. |
Composes heteroaromatiques servant d'inhibiteurs d'une coenzyme stearoyle a delta-9 desaturase
|
|
US8133907B2
(en)
|
2005-07-20 |
2012-03-13 |
Eli Lilly And Company |
Pyridine derivatives as dipeptedyl peptidase inhibitors
|
|
WO2007009911A1
(fr)
|
2005-07-21 |
2007-01-25 |
F. Hoffmann-La Roche Ag |
Composes pyrido [2, 3-d] pyrimidine-2, 4-diamine utilises comme inhibiteurs de ptp1b
|
|
WO2007015744A1
(fr)
|
2005-07-21 |
2007-02-08 |
Incyte Corporation |
Composés thiényl bi-substitués et leur utilisation en tant que produits pharmaceutiques
|
|
ATE480524T1
(de)
|
2005-07-21 |
2010-09-15 |
Hoffmann La Roche |
Pyridazinonderivate als schilddrüsenhormon- rezeptoragonisten
|
|
FR2889189A1
(fr)
|
2005-07-28 |
2007-02-02 |
Cerep Sa |
Composes derives d'hydantoine et leur utilistion en tant qu'antagonistes de mchr-1
|
|
UY29694A1
(es)
|
2005-07-28 |
2007-02-28 |
Boehringer Ingelheim Int |
Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
|
|
CA2617042A1
(fr)
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
Compose spiro-cyclique
|
|
EP1916234B1
(fr)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Composé d'acide cyclopropanecarboxylique
|
|
WO2007017124A1
(fr)
|
2005-07-29 |
2007-02-15 |
Laboratorios Del Dr. Esteve, S.A. |
Phase amorphe d'une pyrazoline substituee, sa preparation et son utilisation comme medicament
|
|
CA2617055A1
(fr)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Preparation et utilisation de derives aminoacides biphenyle pour traiter l'obesite
|
|
WO2007016460A2
(fr)
|
2005-07-29 |
2007-02-08 |
Mayo Foundation For Medical Education And Research |
Reduction de la pression exercee sur la peau pour prevenir les escarres de decubitus par levitation magnetique partielle
|
|
FR2889190A1
(fr)
|
2005-08-01 |
2007-02-02 |
Merck Sante Soc Par Actions Si |
Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
|
|
WO2007016496A2
(fr)
|
2005-08-02 |
2007-02-08 |
Neurogen Corporation |
Dipipérazinyl cétones et analogues apparentés
|
|
CA2617654A1
(fr)
|
2005-08-04 |
2007-02-08 |
Pfizer Limited |
Composes piperidinoyl-pyrrolidine et piperidinoyl-piperidine
|
|
ES2267400B1
(es)
|
2005-08-04 |
2008-03-01 |
Universitat De Valencia |
Composiciones pigmentarias en base acuosa para marcado policromatico de materiales inorganicos con laser.
|
|
WO2007018459A1
(fr)
|
2005-08-08 |
2007-02-15 |
Astrazeneca Ab |
Agents thérapeutiques
|
|
WO2007017649A1
(fr)
|
2005-08-09 |
2007-02-15 |
Astrazeneca Ab |
Dérivés hétéroarylcarbamoylbenzène pour traiter le diabète
|
|
US8143264B2
(en)
|
2005-08-10 |
2012-03-27 |
Glaxosmithkline Llc |
Xanthine derivatives as selective HM74A agonists
|
|
GB0516462D0
(en)
|
2005-08-10 |
2005-09-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
EP1916239A4
(fr)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
Composé de pyridone
|
|
WO2007020502A2
(fr)
|
2005-08-16 |
2007-02-22 |
Pharmacia & Upjohn Company Llc |
Ligands des recepteurs de cannabinoide et utilisations de ceux-ci
|
|
DE602006006712D1
(de)
|
2005-08-18 |
2009-06-18 |
Hoffmann La Roche |
Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
|
|
US7875633B2
(en)
|
2005-08-24 |
2011-01-25 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
US8017624B2
(en)
|
2005-08-26 |
2011-09-13 |
Merck Sharp & Dohme Corp. |
Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
JP2009507791A
(ja)
|
2005-08-29 |
2009-02-26 |
メルク エンド カムパニー インコーポレーテッド |
ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法
|
|
WO2007026215A1
(fr)
|
2005-08-29 |
2007-03-08 |
Glenmark Pharmaceuticals S.A. |
Dérivés de pyrazole tels que les ligands du récepteur de cannabinoïde, compositions pharmaceutiques les contenant et procédés pour leur préparation
|
|
AU2006285834A1
(en)
|
2005-08-31 |
2007-03-08 |
Astellas Pharma Inc. |
Thiazole derivative
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
WO2007028145A2
(fr)
|
2005-09-02 |
2007-03-08 |
Dara Biosciences, Inc. |
Agents et procede permettant de reduire l'activite de la proteine tyrosine phosphatase 1b dans le systeme nerveux central
|
|
EP1931633A2
(fr)
|
2005-09-05 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Derives de 3-azabicyclo[3.1.0]hexane en tant qu'inhibiteurs de la dipeptidyl peptidase-iv
|
|
WO2007029847A1
(fr)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
Dérivé de pyridone substitué aromatique bicylique
|
|
ES2289888B1
(es)
|
2005-09-08 |
2008-12-16 |
Consejo Superior Investig. Cientificas |
Derivados de pirazolcarboxamida, su procedimiento de obtencion y sus aplicaciones como antagonistas/agonistas inversos del receptor cannabinoide cb1 y opioide mu.
|
|
US7582803B2
(en)
|
2005-09-14 |
2009-09-01 |
Amgen Inc. |
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
|
|
GB0518819D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
|
GB0518817D0
(en)
|
2005-09-15 |
2005-10-26 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1928874A1
(fr)
|
2005-09-16 |
2008-06-11 |
AstraZeneca AB |
Composés hétérobicycliques utilisés comme activateurs de la glucokinase
|
|
BRPI0616245A2
(pt)
|
2005-09-16 |
2011-06-14 |
Arena Pharm Inc |
modulador de metabolismo, seus usos, composiÇço farmaceutica compreendendo o mesmo, bem como mÉtodo para produÇço da referida composiÇço
|
|
CN101268099A
(zh)
|
2005-09-21 |
2008-09-17 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y4选择性受体激动剂
|
|
CA2621255A1
(fr)
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Utilisation pharmaceutique de composes amido
|
|
GB0519294D0
(en)
|
2005-09-21 |
2005-11-02 |
Karobio Ab |
Compounds
|
|
EP1934245B1
(fr)
|
2005-09-21 |
2011-07-13 |
7TM Pharma A/S |
Agonistes selectifs du recepteur y2 pour applications therapeutiques
|
|
CA2623525A1
(fr)
|
2005-09-23 |
2007-04-05 |
Janssen Pharmaceutica N.V. |
Modulateurs cannabinoides tetrahydro-indazolyle
|
|
UA93389C2
(en)
|
2005-09-23 |
2011-02-10 |
Янссен Фармацевтика H.B. |
Hexahydro cyclooctyl pyrazole cannabinoid modulators
|
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
|
JP2007091649A
(ja)
|
2005-09-29 |
2007-04-12 |
Taisho Pharmaceut Co Ltd |
ピリミジン誘導体及びその使用に関連する治療方法
|
|
BRPI0616465A2
(pt)
|
2005-09-29 |
2011-06-21 |
Sanofi Aventis |
derivados de fenil-[1,2,4]-oxadiazol-5-ona com grupo fenila, bem como seu uso, composição farmacêutica compreendo os mesmos e processo de preparação da referida composição farmacêutica
|
|
JP4990783B2
(ja)
|
2005-09-30 |
2012-08-01 |
Msd株式会社 |
2−ヘテロアリール置換インドール誘導体
|
|
JP4870163B2
(ja)
|
2005-09-30 |
2012-02-08 |
エフ.ホフマン−ラ ロシュ アーゲー |
Mch受容体アンタゴニストとしてのインダン誘導体
|
|
EP1933836A2
(fr)
|
2005-09-30 |
2008-06-25 |
Merck & Co., Inc. |
Derives de piperidine acylee en tant qu'agonistes du recepteur de la melanocortine 4
|
|
GT200600428A
(es)
|
2005-09-30 |
2007-05-21 |
|
Compuestos organicos
|
|
JP2009513573A
(ja)
|
2005-09-30 |
2009-04-02 |
メルク エンド カムパニー インコーポレーテッド |
コレステリルエステル転送蛋白阻害剤
|
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
|
AR056560A1
(es)
|
2005-10-06 |
2007-10-10 |
Astrazeneca Ab |
Pirrolopiridinonas como moduladores cb1
|
|
DE102005048897A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
FR2891825B1
(fr)
|
2005-10-12 |
2007-12-14 |
Sanofi Aventis Sa |
Derives de la 1-amino-isoquinoline, leur preparation et leur application en therapeutique
|
|
FR2891828B1
(fr)
|
2005-10-12 |
2007-12-21 |
Sanofi Aventis Sa |
Derives de la 1-amino-phtalazine substituee, leur preparation et leur application en therapeutique
|
|
FR2891829A1
(fr)
|
2005-10-12 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de la 4-amino-quinazoline, leur preparation et leur application en therapeutique
|
|
JP2009013065A
(ja)
|
2005-10-14 |
2009-01-22 |
Astellas Pharma Inc |
縮合へテロ環化合物
|
|
EP1937677A1
(fr)
|
2005-10-17 |
2008-07-02 |
Arcadia Pharmaceuticals Inc. |
Composes modulateurs de cb-1 et leur utilisation
|
|
CN103724335A
(zh)
|
2005-10-20 |
2014-04-16 |
默沙东公司 |
用作11β-羟基类固醇脱氢酶-1抑制剂的三唑衍生物
|
|
US8188097B2
(en)
|
2005-10-21 |
2012-05-29 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-A]pyrimidine compounds
|
|
US20070114078A1
(en)
|
2005-11-09 |
2007-05-24 |
Ososanya Esther T |
Super hybrid and enhanced electric cars
|
|
AR057982A1
(es)
|
2005-10-26 |
2008-01-09 |
Boehringer Ingelheim Int |
Compuestos de [hetero) arilo con actividad antagonista de mch y composicion farmaceutica que comprende estos compuestos
|
|
US8618115B2
(en)
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
|
DE102005052101A1
(de)
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
CN101321747A
(zh)
|
2005-11-01 |
2008-12-10 |
詹森药业有限公司 |
作为葡萄糖激酶变构调节剂的取代的环烷基吡咯酮类
|
|
EP1948652B1
(fr)
|
2005-11-01 |
2011-08-24 |
Array Biopharma, Inc. |
Activateurs de glucokinase
|
|
EA200801243A1
(ru)
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
WO2007051811A2
(fr)
|
2005-11-01 |
2007-05-10 |
Transtech Pharma |
Utilisation pharmaceutique d'amides substitues
|
|
US20080293741A1
(en)
|
2005-11-03 |
2008-11-27 |
Matthew Colin Thor Fyfe |
Tricyclo Substituted Amides as Glucokinase Modulators
|
|
JP2009514836A
(ja)
|
2005-11-03 |
2009-04-09 |
プロシディオン・リミテッド |
トリシクロ置換型アミド
|
|
CA2626475A1
(fr)
|
2005-11-03 |
2007-05-10 |
Prosidion Limited |
Amides a substitution tricyclo
|
|
CA2628856A1
(fr)
|
2005-11-08 |
2007-05-18 |
Jordi Frigola-Constansa |
Derives d'indene, leur preparation et leur utilisation en tant que medicaments
|
|
FR2896504B1
(fr)
|
2006-01-23 |
2012-07-13 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|